Indeed, compared with neuroblastoma, in Ewing sarcoma cDCs showed significantly lower expression of NFKB1 and STAT3, confirming their dysfunctional state and involving previously reported signaling pathways in the observed phenotype (Fig. 3F). The gene discussed is NFKB1; the disease is neuroblastoma.